Ancora Advisors’s Anixa Biosciences ANIX Stock Holding History

Ancora Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.29K	Sell	1,275 -247	-16%	-$731	﹤0.01%	2060
2025 Q4	$4.75K	Hold	1,522	–	–	﹤0.01%	1973
2025 Q3	$5.02K	Hold	1,522	–	–	﹤0.01%	1498
2025 Q2	$5.02K	Hold	1,522	–	–	﹤0.01%	1488
2025 Q1	$4.35K	Hold	1,522	–	–	﹤0.01%	1445
2024 Q4	$3.53K	Hold	1,522	–	–	﹤0.01%	1507
2024 Q3	$4.79K	Hold	1,522	–	–	﹤0.01%	1456
2024 Q2	$3.36K	Hold	1,522	–	–	﹤0.01%	1502
2024 Q1	$4.75K	Hold	1,522	–	–	﹤0.01%	1445
2023 Q4	$5.91K	Hold	1,522	–	–	﹤0.01%	1374
2023 Q3	$4.98K	Hold	1,522	–	–	﹤0.01%	1389
2023 Q2	$4.87K	Hold	1,522	–	–	﹤0.01%	1388
2023 Q1	$6.54K	Hold	1,522	–	–	﹤0.01%	1359
2022 Q4	$6K	Sell	1,522 -500	-25%	-$2.4K	﹤0.01%	1436
2022 Q3	$10K	Hold	2,022	–	–	﹤0.01%	1479
2022 Q2	$6K	Buy	2,022 +1,522	+304%	+$4.8K	﹤0.01%	1703
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	2229
2021 Q4	$1K	Buy	+500	New	+$2.02K	﹤0.01%	2266

Other funds holding ANIX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ancora Advisors's ANIX Position: Q1 2026 in Review

Ancora Advisors reduced its Anixa Biosciences (ANIX) stake by 16% in Q1 2026, selling an estimated $731 and leaving 1,275 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Ancora Advisors first reported a position in ANIX in Q4 2021 and has held it in 18 quarters since. The position peaked at $10K in Q3 2022. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

Ancora Advisors held 1,275 shares of Anixa Biosciences worth $3.29K as of Q1 2026.
Ancora Advisors sold 247 Anixa Biosciences shares in Q1 2026, an estimated $731.
Anixa Biosciences made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2060 holding.
Ancora Advisors first reported a position in Anixa Biosciences in Q4 2021 and has held it in 18 quarters since.
Ancora Advisors's Anixa Biosciences position peaked at $10K in Q3 2022.
60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.